HBV Relapse after Discontiniuation of Tenofovir Alafenamide or Entecavir in Non-Cirrhotic Hepatitis B e Antigen-Negative Patients
Patients who discontinued TAF had a higher risk of virological relapse and clinical relapse than those who discontinued ETV. HBsAg levels at EOT may be an appropriate predictor to distinguish the different risks of clinical relapse between patients who have discontinued TAF or ETV.
Authors
- Chung‐Hsin Chang
- Shou‐Wu Lee (ORCID: https://orcid.org/0000-0002-2412-2665)
- Jun‐Sing Wang (ORCID: https://orcid.org/0000-0002-0887-6432)
- Teng‐Yu Lee (ORCID: https://orcid.org/0000-0002-4097-4315)
- Szu‐Chia Liao
- Yi‐Jie Huang (ORCID: https://orcid.org/0009-0002-7864-4474)
- Yen‐Chun Peng
- C. J. Tung
Institutions
- National Yang Ming Chiao Tung University (TW)
- National Chung Hsing University (TW)
- China Medical University (TW)
- Taichung Veterans General Hospital (TW)
- Chung Shan Medical University (TW)
Publication Details
- Journal
- Digestive Diseases
- Published
- 2025-02-21
- DOI
- https://doi.org/10.1159/000544870
- Citations
- 1
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35